SciELO - Scientific Electronic Library Online

 
vol.41 issue2Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian populationOccurrence of killer yeast strains in industrial and clinical yeast isolates author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Biological Research

Print version ISSN 0716-9760

Biol. Res. vol.41 no.2 Santiago  2008

http://dx.doi.org/10.4067/S0716-97602008000200006 

 

Biol Res 41: 165-171, 2008

ARTICLE

Free Radical Scavenging Profile and Myeloperoxidase Inhibition of Extracts from Antidiabetic Plants: Bauhinia forficata and Cissus sicyoides

 

NAJEH M KHALIL, MARIA T PEPATO and IGUATEMY L BRUNETTI*

Clinical Analysis Department, School of Pharmaceutical Sciences, Araraquara - UNESP - Sao Paulo State University, Sao Paulo, Brazil.

Dirección para Correspondencia


ABSTRACT

There is abundant evidence that reactive oxygen species are implicated in several physiological and pathological processes. To protect biological targets from oxidative damage, antioxidants must react with radicáis and other reactive species faster than biological substrates do. The aim of the present study was to determine the in vitro antioxidant activity of aqueous extracts from leaves of Bauhinia forficata Link (Fabaceae - Caesalpinioideae) and Cissus sicyoides L. (Vitaceae) (two medicinal plants used popularly in the control of diabetes mellitus), using several different assay systems, namely, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) decolorization, superoxide anión radical (02•-) scavenging and myeloperoxidase (MPO) activity. In the ABTS assay for total antioxidant activity, B. forficata showed IC50 = 8.00±0.07 μg/mL, while C. sicyoides showed IC50 = 13.0±0.2 μg/mL. However, the extract of C. sicyoides had a stronger effect on 02•- (IC50 = 60.0±2.3 μg/mL) than the extract of B. forficata (IC50 = 90.0±4.4 μg/ mL). B. forficata also had a stronger inhibitory effect on MPO activity, as measured by guaiacol oxidation, than C. sicyoides. These results indicate that aqueous extracts of leaves of B. forficata and C. sicyoides are a potential source of natural antioxidants and may be helpful in the prevention of diabetic complications associated with oxidative stress.

Key terms: ABTS decolorization assay, antioxidant activity, superoxide anión scavenging activity.


 

INTRODUCTION

Leaves of the Bauhinia forficata Link (Fabaceae - Caesalpinioideae) tree (1,2) and Cissus sicyoides L. (Vitaceae) (3), plants Insulin, respectively, are used in folk medicine to treat diabetes mellitus, either together with or in place of conventional treatment (4). Our earlier studies showed that long-term oral treatment with leaf decoction of either B. forficata or C. sicyoides significantly reduced the levéis of blood glucose, urinary glucose and urinary urea (5,6), as well as both the food and fluid intake and the volume of urine excreted, in streptozotocin-diabetic rats (5).

Hyperglycemia, as occurs in diabetes mellitus, can induce oxidative stress by several mechanisms, such as glucose autoxidation, the formation of advanced glycation end-products (AGE) and activation known popularly as Cows Hoof and Plant of the polyol pathway. Such mechanisms genérate reactive oxygen species (ROS) (7).

Besides this, the increased production of ROS by mitochondria in hyperglycemic conditions is recognized as a major cause of the clinical complications associated with diabetes and obesity (8).

Some researchers have demonstrated that patients with increased levéis of circulating markers of free radical-induced damage also exhibit an associated decline in their antioxidant defenses (9,10).

Medicinal plants, especially those that contain flavonoids, exhibit múltiple pharmacological activities (11). Beltrame et al. identified two flavonoids in leaves of C. sicyoides: kaempferol 3-oc-rhamnoside and quercetin 3-oc-rhamnoside (4). Pizzolatti et al. also identified four different flavonoids in B.forficata leaves, with kaempferitrin predominating (12). It is a well-established fact that flavonoids possess antioxidant properties (13). Considerable interest has gathered around the role and use of antioxidants as a means of preventing damage due to the oxidative imbalance found in diabetes. This is because they may help to protect the body against damage by free radicáis and ROS (14). Some of the most important ROS produced in vivo are: superoxide anión radical (02•-), hydrogen peroxide (H202), hypochlorous acid (HOC1) and hydroxyl radical (HO•) (15).

Superoxide anión is one of the ROS formed during the oxidative burst that occurs in numerous pathological events, such as diabetes, atherosclerosis, cardiovascular illnesses, and cáncer (16).

Myeloperoxidase (MPO), an enzyme present in polymorphonuclear neutrophil granulocytes and monocytes, has been found in human atherosclerotic tissue and specific producís of MPO-catalyzed reactions have been detected during all stages of the development of atherosclerosis and other disorders (17,18,19).

In light of these observations, we continued our investigations on extracts of B. forficata and C. sicyoides leaves in this study, by testing the possibility that both plants contain appreciable levéis of antioxidant activity, available under conditions similar to the ir normal use, in folk medicine, namely in prepared decoctions. To this end we assessed the 02•- scavenging activity and the total antioxidant activity, by the ABTS decolorization assay, as well as the effect of these extracts on MPO activity, in leaf decoctions of both plants. Another question explored was the potential usefulness of these tests for the characterization of such extracts.

METHODS

Plant material

Leaves of both B. forficata and C. sicyoides were collected from the Medicinal Plants Garden of the School of Pharmacy, UNESP, Araraquara, Sao Paulo State, Brazil. Leaves of B. forficata were collected between April and May (the end of Autumn in the Southern Hemisphere) and leaves of C. sicyoides were collected in August and September (at the end of Winter). The two plants were identified, authenticated and deposited under accession nos. 119 and 120, respectively, in the Herbarium of the Department of Industrial Pharmacy, Federal University of Santa Maria, Rio Grande do Sul, Brazil, by Dr Gilberto Dolejal Zanetti.

Decoction preparation

The decoction of leaves of B. forficata was prepared by a method typically used in the Araraquara región, i. e. washing, then boiling 150 g of fresh leaves in 1 L of distilled water for 5 min, allowing the decoction to stand for 30 min and filtering it through filter paper. The final yield was 87% by volume. The method utilized for C. sicyoides was similar, with a yield of 94% by volume. The dry extracts were prepared by lyophilizing 36 mL of each decoction, which was the mean volume ingested daily by rats during a one-month trial (6). This procedure was carried out in a Freezone 61 L Benchtop lyophilizer, and the yields were 0.0053 g/mL (3.5%) for B. forficata and 0.0021 g/mL (1.4%) for C. sicyoides.

Reagents

Potassium persulfate, phenazine methosulfate (PMS), nitroblue tetrazolium (NBT), nicotinamide adenine dinucleotide (NADH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), trolox, uric acid, quercetin and MPO were purchased from Sigma Chemical Co. (St. Louis, MO). All other reagents were analytical grade and commercially available.

ABTS Radical Catión Decolorization Assay

The total antioxidant activities of extracts were evaluated by the ABTS radical catión decolorization assay (20). Briefly, a mixture of 7mM ABTS and 2.45 mM potassium persulfate was prepared and allowed to stand at room temperature for 12 h in the dark. The resulting ABTS•+ solution was diluted to an absorbance of 0.70 at 734 nm in 50 mM sodium phosphate buffer, pH 7.4. Phosphate buffer without (0% scavenging control) or with various concentrations of B. forficata and C. sicyoides were added to the ABTS•+ solution. The absorbance at 734 nm was read after 30 minutes. The percentage of scavenging activity (%) was calculated as follows:Scavenging activity = [1-(absorbance of sample at 734 nm)/ absorbance of control at 734 nm)] x 100. Trolox and uric acid were used as positive controls in this assay.

02•- Scavenging Activity in the NADH/ PMS/NBT System

The 02•- scavenging activity of B. forficata and C. sicyoides was determined by the method described by Kakkar et al. (21), slightly modified. Solutions containing 156 ixM NBT dissolved in 50 mM phosphate buffer, pH 7.4, 468 ¡xM NADH and various concentrations of crude extracts were mixed and the reaction started by adding 100 [xL of 60 [xM PMS solution. The reaction mixture was incubated at 25°C for 5 min and absorbance at 560 nm was measured against control samples (without NADH). All tests were performed in triplícate. The percentage of scavenging activity (%) was calculated as follows: Scavenging activity = [l-(absorbance of sample at 560 nm)/ absorbance of control at 560 nm)] x 100. Trolox and uric acid were used as positive controls in this assay.

Activity of MPO

Activity of MPO was also determined spectrophotometrically, with guaiacol as substrate (22). The reaction mixture contained 2.5 nM MPO, 1 mM guaiacol and 0.5 mM H202 in 1.0 mL of 50 mM phosphate buffer, pH 7.4. The mixture was incubated at 37 °C without (control) or with B. forficata or C. sicyoides and the reaction was initiated by the addition of H202, after which the increase of absorbance at 470 nm was recorded for 3 min. MPO activity was calculated from the initial rate of reaction (in s-1). % inhibition = [1-(activity of test)/ activity of control] x 100.

We used a Diode Array 8452 A spectrophotometer from Hewlett Packard, equipped with a thermostatic cell, for all determinations. Quercetin was used as positive control in this assay.

Statistic Analysis

Results are expressed as means ± SD. Statistical significance was determined by Student's t test (p<0.05).

RESULTS AND DISCUSSION

Several total antioxidant assays have been used to determine the antioxidant scavenging activity of plant-based foods (23) and clinical fluids and tissues (24). The ABTS•+ assay has several advantages: it is simple, colorimetric, does not require sophisticated analytical equipment (25) and provides a good estimate of the antioxidant activity of puré compounds and complex matrices. The rate of the decrease in absorbance at 734 nm depends on the type and amount of antioxidants and the results are thus expressed as antioxidant standard equivalents (20,25). Thus, initially we used the ABTS•+ assay to estimate the total antioxidant activity of the extracts. In Figure 1, the suppression of the absorbance of ABTS•+ in a concentration-dependent manner is typically shown by B. forficata and C. sicyoides extracts. In the tested conditions, B. forficata showed a 50% inhibitory concentration of IC50 = 8.00±0.07μg/mL, while C. sicyoides showed IC50 = 13.0±0.2 μg/mL. B. forficata exhibited higher antioxidant activity than C. sicyoides (p<0.05). One hundred percent ABTS scavenging activity was reached only when 25.0 μg/mL of C. sicyoides was used.


Uric acid, an endogenous antioxidant present in extracellular fluids (26), and trolox were used as standard antioxidants, respectively showing IC50 = 1.20 ± 0.03 μg/ mL and IC50 =0.600 ± 0.006 μg/mL. To obtain these IC50 valúes, it was necessary to use concentrations of the plant extracts in the range 0 a 25 μg/mL.

Since the results of the ABTS#+ radical catión assay indicated a potential antioxidant activity in the extracts, we decided to test this effect on the superoxide anión. Figure 2 shows the effects of the B. forficata and C. sicyoides decoctions on the superoxide anión generated by the NADH/ PMS/NBT system. In this assay four different concentrations of each decoction were tested (25; 50; 75; 100 μg/mL). The extract of C. sicyoides had a stronger effect on the superoxide anión (IC50 = 60.0±2.3 μg/mL) than the extract of B. forficata (IC50 = 90.0±4.4μg/mL). At the lowest tested concentration (25 μg/mL), to the C. sicyoides the inhibition was ~ 37%, whereas B. forficata exhibited an inhibition of ~15.0 %. C. sicyoides exhibited stronger antioxidant activity than B. forficata (p<0.05). The generation of superoxide anions was markedly inhibited by superoxide dismutase, with an IC50 of 3.7 μg/mL. In this assay, 0-100 μig/mL of the each plant extract had to be used to obtain the IC50 valúes. Uric acid and trolox were used as standard antioxidants and showed IC50 higher than 100 μg/mL.


Figure 3 shows the effects of B. forficata and C. sicyoides on guaiacol oxidation by MPO. B. forficata had a stronger inhibitory effect on MPO (61% inhibition at 25 μig/mL and 85% at 50 or 100 μg/mL) than did C. sicyoides (48% inhibition at 100 μ/mL). Quercetin, which is an effective antioxidant and inhibitor of MPO (27), exhibited an IC50 of 1.2±0.3 μg/mL. Although the IC50 of the extracts with the MPO/H202/guaiacol system was not determined, it can be estimated that, compared to quercetin, the extracts showed only weak inhibition of this enzyme in vitro. Further research is necessary to elucidate the different mechanisms involved in the interaction of B. forficata and C. sicyoides with MPO.


The human body possesses a series of defenses against ROS formed in vivo, but those defenses are not enough in certain conditions, such as liver cirrhosis, atherosclerosis, cáncer and diabetes, in which there is a higher rate of formation of ROS (28).

It has been found that some plant extracts used in traditional medicines for human diabetes also have a significant antioxidant activity (29). However, the mechanism of action of these drugs in reducing diabetes is not known.

A quite different question that our results may help to illuminate is the standardization of herbal medicines demanded in a recent ruling published by Anvisa, the Brazilian National Health and Sanitation Authority (RDC 48/04, dated 16-04-2004). This ruling has led pharmaceutical companies to use only standard extracts and to set up strict Quality Control in plant-based producís. However, it is only rarely that the active principies of plants used medicinally are known; in the case of B. forficata and C. sicyoides, for example, the compounds acting in the treatment of diabetes are unknown. In this situation, the law permits quality control to be applied to any substance that is regularly present in a defined concentration range in the extract. So far, however, no such compound is known in either plant, which is regularly found and could serve as a molecular marker. Henee, we believe that the tests performed on these plants and the results reported here could be employed in industrial quality control.

In summary, the recognized benefits of antioxidants in the prevention of the complications of diabetes supports the use of B. forficata and C. sicyoides, tested in this study. The continuation of these studies will involve the isolation and identification of the compounds responsible for the beneficial effeets on diabetes and/or antioxidant activity and in vivo tests. Meanwhile, the assays carried out here could potentially be used in the quality control of extracts of these plants, until such time as their respective active principies are discovered.

ACKNOWLEDGEMENTS

We are grateful to Mrs. M. A. Dangona and V. C. O. Alves for their technical assistance.

REFERENCES

1. PANDA S, KAR S (1999) Withania somnífera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. J Ethnopharmacol 67: 233-239.

2. VIANA EP, SANTA-ROSA RS, ALMEIDA SSMS, SANTOS LS (1999) Constituents of the stem bark of Bauhinia guianensis. Fitoterapia 70: 111-112.

3. SILVA GA, ARAÚJO LCL, OGA S, AKISUE G (1997) Estudo toxicológico e farmacológico dos extratos fluidos de Cissus sicyoides L. Rev Bras Farmacogn 5: 143-155.

4. BELTRAME FL, SARTORETTO JL, BAZOTTE RB, CUMAN RN, CORTEZ DAG (2001): Evaluation of the antidiabetic potential of Cissus sicyoides L. (Vitaceae). Quím Nova 24: 783-785.

5. PEPATO MT, BAVIERA AM, VENDRAMINI RC, PÉREZ MPMS, KETTELHUT IC, BRUNETTI IL. (2003) Cissus sicyoides (princess vine) in the long-term treatment of streptozotocin-diabetic rats. Biotechnol Appl Biochem 37: 15-20.

6. PEPATO MT, KELLER EH, BAVIERA AM, KETTELHUT IC, VENDRAMINI RC, BRUNETTI I.L. (2002) Anti-diabetic activity of Bauhinia forficata decoction in streptozotocin-diabetic rats. J Ethnopharmacol 81: 191-197.

7. WOLFF SP, DEÁN RT (1987) Glucose autoxidation and protein modification. The potential role of ;autoxidative glycosylation' in diabetes. Biochem J 245: 243-250.

8. BROWNLEE M (2001): Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.

9. COPPEY LJ, GELLETT JS, DAVIDSON EP, YOREK MA (2003) Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radie Res 37: 33-40.

10. MARTÍN-GALLAN P, CARRASCOSA A, GUSSINYE M, DOMÍNGUEZ C (2003) Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radie Biol Med 34: 1563 -1574.

11. JANBAZ KH, SAEED SA, GILANI AH (2002) Protective effect of rutin on paracetamol- and CC14-induced hepatotoxicity in rodents. Fitoterapia 73: 557-563.

12. PIZZOLATTI MG, CUNHA JA, SZPOGANICZ B, DE SOUZA E, BRAZ-FILHO R, SCHRIPSEMA J (2003) Flavonóides Glicosilados das Folhas e Flores de Bauhinia forficata (Leguminosae) Química Nova 26: 466-469.

13. URQUIAGA I, LEIGHTON F (2000) Plant polyphenol antioxidants and oxidative stress. Biol Res 33: 55-64.

14. HALLIWELL B, AESCHBACH R, LÓLIGER J, ARUOMA Oí (1995) The characterization of antioxidants. Food Chem Toxicol 33: 601-617.

15. HAMPTON MB, KETTLE AI, WINTERBOURN CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92: 3007-3017.

16. ZALBA G (2005) NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. Antioxid. Redox Signal 7: 1327-1336.

17. HEINECKE JW (1997) Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 8: 268-274.

18. DAUGHERTY A, RATERI DL, DUNN JL, HEINECKE JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94: 437-444.

19. ZHANG R, BRENNAN ML, FU X, AVILES RJ, PEARCE GL, PENN MS, TOPOL EJ, SPRECHER DL, HAZEN SL (2001) Association between myeloperoxidase levéis and risk of coronary artery disease. JAMA 286: 2136-2142.

20. RE R, PELLEGRINI N, PROTEGGENTE A, PANNALA A, YANG M, RICE-EVANS C (1999) Antioxidant activity applying an improved ABTS radical catión decolorization assay. Free Radie Biol Med 26: 1231-1237.

21. KAKKAR P, DAS B, VISWANATHAN PN (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21: 130-132.

22. NISHIOKA T, MAKI K, KIMURA M, TAKAHAMA U (2003) Determination of salivary peroxidase activity in human mixed whole saliva. Arch Oral Biol 48: 397-400.

23. ARNAO MB, CANO A, ACOSTA M (1999): Methods to measure the antioxidant activity in plant material. A comparative discussion. Free Radie Res 31: S89-S96.

24. GHISELLI A, SERAFINI M, NATELLA F, SCACCINI C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radie Biol Med 29: 1106-1014.

25. JOHNSTON JW, DUSSERT S, GALE S, NADARAJAN J, HARDING K, BENSON EE (2006) Optimization of the azinobis-3-ethyl-benzothiazoline-6-sulphonic acid radical scavenging assay for physiological studies of total antioxidant activity in woody plant germplasm. Plant Physiol Biochem 44: 193-201.

26. STINEFELT B, LEONARD SS, BLEMINGS KP, SHI K, KLANDORF H (2005) Free radical scavenging, DNA protection, and inhibition of lipid peroxidation mediated by uric acid. Ann Clin Lab Sci 35: 37-45.

27. REGASINI LO, VELLOSA JC, SILVA DH, FURLAN M, DE OLIVEIRA OM, KHALIL NM, BRUNETTI IL, YOUNG MC, BARREIRO EJ, BOLZANI VS (2008) Phytochemistry. 69: 1739-44.

28. DROGE W (2002) Free radicáis in the physiological control of cell function. Physiol Rev 82: 47-95.

29. SABU MC, KUTTAN R (2002) Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81: 155-160.

*Corresponding Author: Prof. Dr. Iguatemy Lourenco Brunetti, Departamento de Análises Clínicas, Faculdade de Ciencias Farmacéuticas de Araraquara, Universidade Estadual Paulista Joelio de Mesquita Filho - UNESP, Rúa Expedicionarios do Brasil n. 1621, Araraquara - SP, Brazil 14801- 902, Phone/Fax: 55 16 3301 6559, E-mail: brunetti@fcfar.unesp.br

Received: April 1, 2008. In Revised form: May 20, 2008. Accepted: June 11, 2008.

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License